Holen Sie sich die Stockscreener-App
26.00
11.83%
2.75
Handel nachbörslich:
26.12
0.12
+0.46%
Enliven Therapeutics Inc Aktie (ELVN) Neueste Nachrichten
Enliven Therapeutics stock hits 52-week high at $25.64 By Investing.com - Investing.com India
Enliven Therapeutics stock hits 52-week high at $25.64 - Investing.com
Enliven Therapeutics Early Leukemia Drug Results Impress, Stock Soars - Sahm
Assessing Enliven Therapeutics (ELVN) Valuation After Encouraging Phase 1b ENABLE Trial Data - Yahoo Finance UK
How Enliven Therapeutics Inc. stock reacts to oil prices2025 Analyst Calls & Long-Term Growth Stock Strategies - ulpravda.ru
What risks investors should watch in Enliven Therapeutics Inc. stockMarket Trend Report & Expert Approved Momentum Trade Ideas - ulpravda.ru
Enliven touts drug trial results, adds pharma exec to board - BizWest
Why Enliven Therapeutics Inc. stock could benefit from AI revolutionMarket Risk Report & Community Shared Stock Ideas - ulpravda.ru
Enliven Therapeutics’ Initial Leukemia Drug Data Excite Investors, Shares Surge - Bitget
Will Enliven Therapeutics Inc. stock see insider buyingWeekly Stock Report & AI Forecasted Stock Moves - ulpravda.ru
Enliven Stock Soars 51% After Positive CML Trial Results - Nasdaq
How supply chain issues affect Enliven Therapeutics Inc. stock2025 Retail Activity & Free Risk Controlled Daily Trade Plans - ulpravda.ru
Shorts Report: How Enliven Therapeutics Inc. stock reacts to oil pricesFed Meeting & Daily Oversold Stock Bounce Ideas - ulpravda.ru
Enliven surges on trial data for leukemia drug (ELVN:NASDAQ) - Seeking Alpha
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
ELVN Stock Shot Up 60% Today – What’s Driving The Rally? - Stocktwits
How resilient is Enliven Therapeutics Inc. stock in market downturns2025 Volatility Report & Daily Entry Point Trade Alerts - ulpravda.ru
Enliven Stock Soars On Promising Phase 1b Data In Chronic Myeloid Leukaemia - Nasdaq
Enliven reports positive initial phase 1b data for ELVN-001 in CML By Investing.com - Investing.com South Africa
Enliven reports positive initial phase 1b data for ELVN-001 in CML - Investing.com Canada
Enliven Reports Positive Initial Phase 1b Data for ELVN-001 in CML and Outlines 2026 Clinical Milestones - PR Newswire
Enliven Therapeutics continues to prepare for phase 3 trial initiation in 2026 - MarketScreener
Scott Garland joins Enliven Therapeutics board as company prepares for CML trial - Investing.com Nigeria
Veteran cancer-drug leader joins company pushing new CML drug to Phase 3 - Stock Titan
Enliven Therapeutics, Inc. (NASDAQ:ELVN) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
Earnings Risk: How Enliven Therapeutics Inc stock reacts to oil prices2025 Sector Review & Daily Chart Pattern Signals - moha.gov.vn
Enliven Therapeutics, Inc. (NASDAQ:ELVN) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Avoiding Lag: Real-Time Signals in (ELVN) Movement - Stock Traders Daily
Enliven Therapeutics CSO sells $84k in shares By Investing.com - Investing.com Nigeria
Enliven Therapeutics (NASDAQ:ELVN) Insider Joseph Lyssikatos Sells 5,000 Shares of Stock - MarketBeat
Enliven Therapeutics CSO sells $84k in shares - Investing.com
Enliven Therapeutics (NASDAQ:ELVN) Stock Price Down 6.1%Here's What Happened - MarketBeat
First Week of February 2026 Options Trading For Enliven Therapeutics (ELVN) - Nasdaq
Portfolio Shifts: Is Enliven Therapeutics Inc. stock near bottom after decline2025 Volatility Report & Daily Entry Point Trade Alerts - moha.gov.vn
Will Enliven Therapeutics Inc. stock benefit from AI adoption2025 Top Decliners & Fast Exit/Entry Strategy Plans - Улправда
Is Enliven Therapeutics Inc. stock near bottom after declineFed Meeting & Free Weekly Watchlist of Top Performers - Улправда
Technical Reactions to ELVN Trends in Macro Strategies - Stock Traders Daily
Is Enliven Therapeutics Inc. stock a buy before product launchesJuly 2025 Volume & Verified Stock Trade Ideas - DonanımHaber
Enliven Therapeutics Earnings Notes - Trefis
Will Enliven Therapeutics Inc. stock gain from strong economy2025 Biggest Moves & Real-Time Buy Zone Alerts - Улправда
Enliven Therapeutics (ELVN) Stock Analysis Report | Financials & Insights - Benzinga
Enliven Therapeutics (NASDAQ: ELVN) registers shares for 2025 equity inducement plan - Stock Titan
Enliven Therapeutics, Inc.Common Stock (NQ: ELVN - Markets Financial Content
VIX Spike: How resilient is Enliven Therapeutics Inc stock in market downturnsQuarterly Trade Report & Risk Managed Investment Signals - moha.gov.vn
5AM Venture Management LLC Reduces Stock Holdings in Enliven Therapeutics, Inc. $ELVN - Defense World
CEO moves at Prolynx, Centessa, Kyowa Kirin, Enliven, Expression - BioCentury
Enliven Therapeutics (ELVN) officer-director discloses no owned securities - Stock Titan
Enliven Therapeutics (NASDAQ:ELVN) COO Anish Patel Sells 6,663 Shares of Stock - MarketBeat
Enliven Therapeutics Reports Inducement Grants as Permitted by the Nasdaq Listing Rules - Nasdaq
Enliven Therapeutics (NASDAQ:ELVN) Shares Down 6.5% Following Insider Selling - MarketBeat
Enliven Therapeutics appoints Rick Fair as new CEO - Investing.com
Enliven Therapeutics, Inc. Announces Management Changes - marketscreener.com
Enliven Therapeutics appoints Rick Fair as new CEO, shares down - TradingView — Track All Markets
Enliven Therapeutics Appoints Rick Fair as CEO - marketscreener.com
Enliven Therapeutics appoints Rick Fair as new CEO By Investing.com - Investing.com South Africa
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):